Atlas Trials

VistaGen Therapeutics, Inc.

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch VistaGen Therapeutics, Inc.

RecordFirmDate
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (NCT06809179)VistaGen Therapeutics, Inc.2025-01-09
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4) (NCT06615557)VistaGen Therapeutics, Inc.2024-09-16
Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3) (NCT06358651)VistaGen Therapeutics, Inc.2024-03-28
AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia (NCT04147949)VistaGen Therapeutics, Inc.2022-08-01
AV-101 Alone and in Combination With Probenecid in Healthy Subjects (NCT05280054)VistaGen Therapeutics, Inc.2021-12-23
PH94B in the Treatment of Adjustment Disorder With Anxiety (NCT04404192)VistaGen Therapeutics, Inc.2021-10-12
Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD) (NCT05030350)VistaGen Therapeutics, Inc.2021-10-01
PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2 (NCT05011396)VistaGen Therapeutics, Inc.2021-08-30
PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge (NCT04754802)VistaGen Therapeutics, Inc.2021-05-24
AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression (NCT03078322)VistaGen Therapeutics, Inc.2018-03-05

Track VistaGen Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.